blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2980219

EP2980219 - HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.09.2019
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  12.10.2018
FormerGrant of patent is intended
Status updated on  06.10.2018
FormerExamination is in progress
Status updated on  17.09.2018
FormerGrant of patent is intended
Status updated on  13.06.2018
FormerExamination is in progress
Status updated on  17.02.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, HU		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
International Institute of Cancer Immunology, Inc.
13-9, Enoki-cho
Suita-shi, Osaka 564-0053 / JP
[2016/05]
Inventor(s)01 / SUGIYAMA, Haruo
2-19-30 Senbanishi, Minoo-shi
Osaka 562-0036 / JP
 [2016/05]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[2018/46]
Former [2016/05]von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
Application number, filing date15181734.314.12.2007
[2016/05]
Priority number, dateJP2006035535628.12.2006         Original published format: JP 2006355356
[2016/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2980219
Date:03.02.2016
Language:EN
[2016/05]
Type: B1 Patent specification 
No.:EP2980219
Date:14.11.2018
Language:EN
[2018/46]
Search report(s)(Supplementary) European search report - dispatched on:EP23.10.2015
ClassificationIPC:C12N15/12, A61K31/7088, A61K38/00, A61K48/00, A61P35/00, A61P35/02, C07K14/82, C12Q1/02, G01N33/574, // C12N15/00
[2016/05]
CPC:
C07K14/4748 (EP,US); C07K14/82 (KR); A61K39/001153 (EP,KR,US);
A61K38/00 (EP,KR,US); A61K39/4611 (EP,KR); A61K39/464453 (EP,KR);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P37/04 (EP); C12N15/11 (KR); G01N33/574 (EP,US);
A61K2039/5158 (US); A61K2039/57 (EP,US); A61K2039/572 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/37]
Former [2016/05]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:HLA-A*1101-BESCHRÄNKTES WT1-PEPTID UND PHARMAZEUTISCHE ZUSAMMENSETZUNG DAMIT[2016/05]
English:HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME[2016/05]
French:PEPTIDE WT1 À RESTRICTION HLA-A*1101 ET COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI[2016/05]
Examination procedure03.08.2016Amendment by applicant (claims and/or description)
03.08.2016Examination requested  [2016/37]
15.02.2017Despatch of a communication from the examining division (Time limit: M04)
22.06.2017Reply to a communication from the examining division
01.12.2017Despatch of a communication from the examining division (Time limit: M02)
08.03.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.05.2018Reply to a communication from the examining division
14.06.2018Communication of intention to grant the patent
10.09.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.09.2018Fee for grant paid
10.09.2018Fee for publishing/printing paid
05.10.2018Information about intention to grant a patent
05.10.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07850650.8  / EP2098595
EP10191234.3  / EP2341142
EP12164856.2  / EP2479276
Divisional application(s)EP15201329.8  / EP3026115
Opposition(s)15.08.2019No opposition filed within time limit [2019/43]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
07.05.2018Request for further processing filed
07.05.2018Full payment received (date of receipt of payment)
Request granted
22.05.2018Decision despatched
Fees paidRenewal fee
20.08.2015Renewal fee patent year 03
20.08.2015Renewal fee patent year 04
20.08.2015Renewal fee patent year 05
20.08.2015Renewal fee patent year 06
20.08.2015Renewal fee patent year 07
20.08.2015Renewal fee patent year 08
18.12.2015Renewal fee patent year 09
29.12.2016Renewal fee patent year 10
05.12.2017Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.12.2007
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
IE14.12.2018
LU14.12.2018
MT14.12.2018
BE31.12.2018
CH31.12.2018
LI31.12.2018
FR14.01.2019
BG14.02.2019
GB14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
[2020/32]
Former [2020/17]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
IE14.12.2018
LU14.12.2018
MT14.12.2018
BE31.12.2018
CH31.12.2018
LI31.12.2018
FR14.01.2019
BG14.02.2019
GB14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
Former [2020/11]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
IE14.12.2018
LU14.12.2018
MT14.12.2018
BE31.12.2018
CH31.12.2018
LI31.12.2018
FR14.01.2019
BG14.02.2019
GB14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
Former [2020/08]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
IE14.12.2018
LU14.12.2018
MT14.12.2018
BE31.12.2018
CH31.12.2018
LI31.12.2018
FR14.01.2019
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
Former [2020/04]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
IE14.12.2018
LU14.12.2018
BE31.12.2018
CH31.12.2018
LI31.12.2018
FR14.01.2019
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
Former [2019/50]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
IE14.12.2018
LU14.12.2018
BE31.12.2018
FR14.01.2019
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
Former [2019/49]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
IE14.12.2018
LU14.12.2018
FR14.01.2019
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
DE02.07.2019
Former [2019/48]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SK14.11.2018
IE14.12.2018
LU14.12.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/40]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SK14.11.2018
LU14.12.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/39]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SK14.11.2018
LU14.12.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/37]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/35]AT14.11.2018
CZ14.11.2018
DK14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/34]AT14.11.2018
DK14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/26]AT14.11.2018
ES14.11.2018
FI14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/24]AT14.11.2018
ES14.11.2018
FI14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
Former [2019/23]AT14.11.2018
ES14.11.2018
FI14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
BG14.02.2019
IS14.03.2019
Former [2019/22]FI14.11.2018
LT14.11.2018
BG14.02.2019
IS14.03.2019
Former [2019/21]FI14.11.2018
LT14.11.2018
IS14.03.2019
Former [2019/20]LT14.11.2018
Documents cited:Search[Y]US2003082196  (GAIGER ALEXANDER [US], et al) [Y] 1-13 * the whole document *;
 [X]JP2006280324  (UNIV EHIME) [X] 1-13 * the whole document *;
 [E]WO2010037395  (DAKO DENMARK AS [DK], et al) [E] 1-13* the whole document *;
 [X]  - "Human Wilms tumor-1 antigen peptide fragment SEQ ID No 30.", Geneseq, (20061214), Database accession no. AEL42683, URL: EBI, XP002745587 [X] 1-13 * abstract *
 [Y]  - VAN DRIESSCHE A ET AL, "Antigen-specific cellular immunotherapy of leukemia", LEUKEMIA (BASINGSTOKE), (200511), vol. 19, no. 11, ISSN 0887-6924, pages 1863 - 1871, XP002565480 [Y] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.leu.2403930
by applicantWO0228414
 WO03106682
 WO2005095598
 JP2006045287
    - DANIEL A. HABER ET AL., CELL, (19900629), vol. 61, no. 7, pages 1257 - 69
    - CALL KM ET AL., CELL, (19900209), vol. 60, no. 3, pages 509 - 20
    - MENKE AL ET AL., INT REV CYTOL., (1998), vol. 181, pages 151 - 212
    - YAMAGAMI T ET AL., BLOOD, (19960401), vol. 87, no. 7, pages 2878 - 84
    - INOUE K ET AL., BLOOD, (19980415), vol. 91, no. 8, pages 2969 - 76
    - TSUBOI A ET AL., LEUK RES., (199905), vol. 23, no. 5, pages 499 - 505
    - OKA Y ET AL., J IMMUNOL., (20000215), vol. 164, no. 4, pages 1873 - 80
    - MELIEF CJ ET AL., IMMUNOL REV, (199506), vol. 145, pages 167 - 77
    - RITZ J, J CLIN ONCOL, (199402), vol. 12, no. 2, pages 237 - 8
    - TSUBOI A ET AL., J CLIN IMMUNOL., (200005), vol. 20, no. 3, pages 195 - 202
    - OKA Y ET AL., IMMUNOGENETICS, (200002), vol. 51, no. 2, pages 99 - 107
    - OHMINAMI H ET AL., BLOOD, (20000101), vol. 95, no. 1, pages 286 - 93
    - GAO L ET AL., BLOOD, (20000401), vol. 95, no. 7, pages 2198 - 203
    - The Proteins, ACADEMIC PRESS INC., (1976), vol. 2
    - Iyakuhin No Kaihatsu (Zoku, (1991), vol. 14
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.